Bionor appoints new CFO
This article was originally published in Scrip
Executive Summary
Oslo, Norway-based Bionor Pharma, a peptide vaccine company working in the area of HIV, has named Jens Krøis chief financial officer. Mr Krøis has more than 20 years' financial management experience across the Nordic regions and internationally. His previous roles include vice-president of business analysis at AMBU, a publicly listed Danish healthcare company, CFO of global customer service at FLSmidth & Co and executive CFO of Connection. Mr Krøis replaces chief operating officer Søren Keller, who had been serving as CFO in an interim role.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.